171 related articles for article (PubMed ID: 25569159)
1. Genome-wide identification of CBX2 targets: insights in the human sex development network.
Eid W; Opitz L; Biason-Lauber A
Mol Endocrinol; 2015 Feb; 29(2):247-57. PubMed ID: 25569159
[TBL] [Abstract][Full Text] [Related]
2. CBX2-dependent transcriptional landscape: implications for human sex development and its defects.
Sproll P; Eid W; Biason-Lauber A
Sci Rep; 2019 Nov; 9(1):16552. PubMed ID: 31719618
[TBL] [Abstract][Full Text] [Related]
3. CBX2 in DSD: The Quirky Kid on the Block.
Hart D; Rodríguez Gutiérrez D; Biason-Lauber A
Sex Dev; 2022; 16(2-3):162-170. PubMed ID: 35263754
[TBL] [Abstract][Full Text] [Related]
4. Assembling the jigsaw puzzle: CBX2 isoform 2 and its targets in disorders/differences of sex development.
Sproll P; Eid W; Gomes CR; Mendonca BB; Gomes NL; Costa EM; Biason-Lauber A
Mol Genet Genomic Med; 2018 Sep; 6(5):785-795. PubMed ID: 29998616
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional regulator CBX2 and ovarian function: A whole genome and whole transcriptome approach.
Bouazzi L; Sproll P; Eid W; Biason-Lauber A
Sci Rep; 2019 Nov; 9(1):17033. PubMed ID: 31745224
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of CBX2 controls its nucleosome-binding specificity.
Kawaguchi T; Machida S; Kurumizaka H; Tagami H; Nakayama JI
J Biochem; 2017 Nov; 162(5):343-355. PubMed ID: 28992316
[TBL] [Abstract][Full Text] [Related]
7. CBX2 gene analysis in patients with 46,XY and 46,XX gonadal disorders of sex development.
Norling A; Hirschberg AL; Iwarsson E; Wedell A; Barbaro M
Fertil Steril; 2013 Mar; 99(3):819-826.e3. PubMed ID: 23219007
[TBL] [Abstract][Full Text] [Related]
8.
Chao Q; Shen F; Xue Y; Wu J; Zhang J
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075028
[TBL] [Abstract][Full Text] [Related]
9. Cbx2 targets PRC1 to constitutive heterochromatin in mouse zygotes in a parent-of-origin-dependent manner.
Tardat M; Albert M; Kunzmann R; Liu Z; Kaustov L; Thierry R; Duan S; Brykczynska U; Arrowsmith CH; Peters AH
Mol Cell; 2015 Apr; 58(1):157-71. PubMed ID: 25801166
[TBL] [Abstract][Full Text] [Related]
10. CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway.
Del Gaudio N; Di Costanzo A; Liu NQ; Conte L; Dell'Aversana C; Bove G; Benedetti R; Montella L; Ciardiello F; Carafa V; Ambrosino C; Tucci V; Conte M; Martens JHA; Stunnenberg HG; Nebbioso A; Altucci L
Mol Cancer; 2022 Jun; 21(1):125. PubMed ID: 35681235
[TBL] [Abstract][Full Text] [Related]
11. Cell type-specific role of CBX2 and its disordered region in spermatogenesis.
Kim JJ; Steinson ER; Lau MS; de Rooij DG; Page DC; Kingston RE
Genes Dev; 2023 Jul; 37(13-14):640-660. PubMed ID: 37553262
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma.
Piqué DG; Montagna C; Greally JM; Mar JC
Br J Cancer; 2019 Apr; 120(7):746-753. PubMed ID: 30820027
[TBL] [Abstract][Full Text] [Related]
13. Cbx2, a polycomb group gene, is required for Sry gene expression in mice.
Katoh-Fukui Y; Miyabayashi K; Komatsu T; Owaki A; Baba T; Shima Y; Kidokoro T; Kanai Y; Schedl A; Wilhelm D; Koopman P; Okuno Y; Morohashi K
Endocrinology; 2012 Feb; 153(2):913-24. PubMed ID: 22186409
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2.
Xing Y; Ba-Tu J; Dong C; Cao X; Li B; Jia X; Juan Y; Lv X; Zhang H; Qin N; Han W; Wang D; Qi X; Wang Y; Hao X; Zhang S; Du X; Wang H; Wang M
Cell Death Dis; 2023 Nov; 14(11):782. PubMed ID: 38030604
[TBL] [Abstract][Full Text] [Related]
15. [The expression and significance of chromobox protein homolog 2 in breast cancer].
Guo XH; Zhang JY; Jiao DC; Zhu JJ; Ma YZ; Yang Y; Xiao H; Liu ZZ
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(2):130-135. PubMed ID: 31937053
[No Abstract] [Full Text] [Related]
16. Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.
Clermont PL; Crea F; Chiang YT; Lin D; Zhang A; Wang JZ; Parolia A; Wu R; Xue H; Wang Y; Ding J; Thu KL; Lam WL; Shah SP; Collins CC; Wang Y; Helgason CD
Clin Epigenetics; 2016; 8():16. PubMed ID: 26877821
[TBL] [Abstract][Full Text] [Related]
17. The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
Di Costanzo A; Del Gaudio N; Conte L; Dell'Aversana C; Vermeulen M; de Thé H; Migliaccio A; Nebbioso A; Altucci L
Oncogene; 2018 May; 37(19):2559-2572. PubMed ID: 29467492
[TBL] [Abstract][Full Text] [Related]
18. Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role.
Clermont PL; Sun L; Crea F; Thu KL; Zhang A; Parolia A; Lam WL; Helgason CD
Br J Cancer; 2014 Oct; 111(8):1663-72. PubMed ID: 25225902
[TBL] [Abstract][Full Text] [Related]
19. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
20. The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation.
Liu H; Li Z; Li L
Comput Biol Chem; 2018 Jun; 74():339-346. PubMed ID: 29723807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
